APA (7th ed.) Citation

Akie Okada, Rina Niki, Yutaka Inoue, Junki Tomita, Hiroaki Todo, Shoko Itakura, & Kenji Sugibayashi. (2022). Development of Self-Administered Formulation to Improve the Bioavailability of Leuprorelin Acetate. MDPI AG.

Chicago Style (17th ed.) Citation

Akie Okada, Rina Niki, Yutaka Inoue, Junki Tomita, Hiroaki Todo, Shoko Itakura, and Kenji Sugibayashi. Development of Self-Administered Formulation to Improve the Bioavailability of Leuprorelin Acetate. MDPI AG, 2022.

MLA (9th ed.) Citation

Akie Okada, et al. Development of Self-Administered Formulation to Improve the Bioavailability of Leuprorelin Acetate. MDPI AG, 2022.